A systematic review on the functional role of Th1/Th2 cytokines in type 2 diabetes and related metabolic complications.


Journal

Cytokine
ISSN: 1096-0023
Titre abrégé: Cytokine
Pays: England
ID NLM: 9005353

Informations de publication

Date de publication:
02 2020
Historique:
received: 30 05 2019
revised: 09 09 2019
accepted: 14 10 2019
pubmed: 11 11 2019
medline: 30 6 2021
entrez: 10 11 2019
Statut: ppublish

Résumé

The T-helper (Th1/Th2) paradigm is widely studied for its role in modulating an adaptive immune response, especially in relation to the onset of various autoimmune diseases. In fact, emerging evidence clearly shows an inverse relationship between Th1/Th2 cytokines and the development of type 2 diabetes (T2D) complications, which is accelerated by an exacerbated inflammatory state. Here, relevant studies reporting on any association between the levels of Th1/Th2 cytokines and the development of T2D were retrieved through major electronic databases such as The Cochrane Library, Embase and PubMed. Extracted evidence which mostly involved animal models and human subjects with T2D or metabolic syndrome was assessed for quality and risk of bias using the Downs and Black checklist and Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines. Results strongly correlated raised Th1/Th2 cytokines such as interferon-gamma (IFN-γ)/interleukin (IL)-5 and IL-2/IL-5 ratios to T2D, and this was positively linked with the other complications including retinopathy and cardiovascular complications. Further, logistic regression analysis demonstrated that the Th1/Th2 ratios were significantly associated with impaired glucose homeostasis, abnormally enhanced lipid profiles, and insulin resistance. Although more studies making use of a larger sample size are required, current data suggest that optimal modulation of Th1/Th2 cytokines may be an important aspect in the management of T2D and its associated complications.

Identifiants

pubmed: 31704479
pii: S1043-4666(19)30321-7
doi: 10.1016/j.cyto.2019.154892
pii:
doi:

Substances chimiques

Cytokines 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

154892

Subventions

Organisme : FIC NIH HHS
ID : D43 TW010131
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Thabsile Mahlangu (T)

School of Laboratory Medicine and Medical Sciences (SLMMS), College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa.

Phiwayinkosi V Dludla (PV)

Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg 7505, South Africa; Department of Life and Environmental Sciences, Polytechnic University of Marche, Ancona 60131, Italy. Electronic address: pdludla@mrc.ac.za.

Tawanda M Nyambuya (TM)

School of Laboratory Medicine and Medical Sciences (SLMMS), College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa; Department of Health Sciences, Faculty of Health and Applied Sciences, Namibia University of Science and Technology, Windhoek 9000, Namibia. Electronic address: mnyambuya@nust.na.

Vuyolwethu Mxinwa (V)

School of Laboratory Medicine and Medical Sciences (SLMMS), College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa.

Sithandiwe E Mazibuko-Mbeje (SE)

Department of Life and Environmental Sciences, Polytechnic University of Marche, Ancona 60131, Italy; Division of Medical Physiology, Faculty of Health Sciences, Stellenbosch University, Tygerberg 7505, South Africa. Electronic address: sithandiwe.mazibuko@mrc.ac.za.

Ilenia Cirilli (I)

Department of Life and Environmental Sciences, Polytechnic University of Marche, Ancona 60131, Italy. Electronic address: i.cirilli@pm.univpm.it.

Fabio Marcheggiani (F)

Department of Life and Environmental Sciences, Polytechnic University of Marche, Ancona 60131, Italy. Electronic address: f.marcheggiani@univpm.it.

Luca Tiano (L)

Department of Life and Environmental Sciences, Polytechnic University of Marche, Ancona 60131, Italy. Electronic address: l.tiano@staff.univpm.it.

Johan Louw (J)

Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg 7505, South Africa; Department of Biochemistry and Microbiology, University of Zululand, KwaDlangezwa 3886, South Africa. Electronic address: johan.louw@mrc.ac.za.

Bongani B Nkambule (BB)

School of Laboratory Medicine and Medical Sciences (SLMMS), College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa. Electronic address: nkambuleb@ukzn.ac.za.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH